Hsieh Sen-Yung, Hsieh Pei-Shan, Chiu Cheng-Tang, Chen Wai-Ying
Liver Research Unit, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.
Oncogene. 2004 Dec 9;23(57):9183-9. doi: 10.1038/sj.onc.1208138.
To identify putative tumor suppressor genes in hepatocarcinogenesis, we combined the representational difference analysis and reverse northern blot identifying downregulated genes in human hepatoma tissues. One of them was Dkk-3/REIC. Dkk-3/REIC was downregulated in 11 out of the 20 human hepatoma tissues as compared to their counterparts of noncancerous liver tissues by northern blot analysis. It was also downregulated in 29 out of 48 human cancer samples including the kidney, urinary bladder, prostate, pancreas and lung cancers. Its gene product, Dkk-3/REIC, was found to be N-glycosylated and have two isoforms, the 55 kDa in the cytosol and 50 kDa secreted in the medium. Ectopic expression of Dkk-3/REIC in HeLa, Hep3B and Huh 7 cells led to suppression of cell growth, which was primarily attributable to induction of cell apoptosis. The suppression phenomenon was found to be cell-type related (most prominent in HeLa and least in Hep3B cells) and cell-density dependent (attenuated as the cell density increased). Transduction of Dkk-3/REIC into HeLa and Hep3B cells caused suppression on colony formation in vitro and reduced tumor growth rate in inoculated athymic nude mice. In conclusion, these data indicate that Dkk-3/REIC functions as a suppressor for human tumor growth.
为了在肝癌发生过程中鉴定潜在的肿瘤抑制基因,我们将代表性差异分析与反向Northern印迹相结合,以鉴定人肝癌组织中下调的基因。其中之一是Dkk-3/REIC。通过Northern印迹分析,与癌旁肝组织相比,20例人肝癌组织中有11例Dkk-3/REIC表达下调。在包括肾癌、膀胱癌、前列腺癌、胰腺癌和肺癌在内的48例人类癌症样本中,有29例Dkk-3/REIC表达也下调。发现其基因产物Dkk-3/REIC为N-糖基化,有两种异构体,胞质中的55 kDa和培养基中分泌的50 kDa。Dkk-3/REIC在HeLa、Hep3B和Huh 7细胞中的异位表达导致细胞生长受到抑制,这主要归因于细胞凋亡的诱导。发现这种抑制现象与细胞类型有关(在HeLa细胞中最明显,在Hep3B细胞中最不明显)且与细胞密度有关(随着细胞密度增加而减弱)。将Dkk-3/REIC转导到HeLa和Hep3B细胞中会导致体外集落形成受到抑制,并降低接种无胸腺裸鼠的肿瘤生长速率。总之,这些数据表明Dkk-3/REIC作为人类肿瘤生长的抑制剂发挥作用。